Getting Coal in Your Stocking May Be Exactly What You Want
Source: Chris Vermeulen, TheGoldAndOilGuy  (12/18/12)
"The only individuals who would appreciate a dirty gift like coal would be those forward-looking investors who see major opportunities before they become the next big movers and headline news." More >

Now Is the Time to Buy These Oil Refiners and Coal Stocks
Source: Kent Moors, Oil & Energy Investor  (12/18/12)
"There will be several beneficiaries in the energy sector as hedge fund managers make their moves over the next few weeks." More >

What on Earth's Going on in the Gold Market?
Source: Lawrence Williams, Mineweb  (12/18/12)
"Virtually everything that is happening in the global economy suggests that the gold price should be rising, and probably rising fast, yet it has been unable to move out of a trading range of $1680–1750, and every time it nears the top of this range it gets knocked back again." More >

CIBC's Matt Gibson Sees Upside in Iron in 2013
Source: Brian Sylvester of The Gold Report  (12/17/12)
Investors who want to play in the iron and copper space should look to small-cap producers for attractive valuations and lower risk, says Matt Gibson, institutional research analyst with CIBC World Markets. In this Gold Report interview, he says he believes iron has found its floor in 2012 and names iron ore and copper companies with upside potential. More >

Silver’s Young Upleg
Source: Adam Hamilton, Zeal Research   (12/16/12)
"Although you wouldn’t know it from listening to all the bearish commentary out there, silver is actually enjoying a strong young upleg." More >

Golden Points To Ponder
Source: Rick Mills, Ahead of the Herd  (12/15/12)
"Despite increased exploration expenditures, a record US$8B in 2011, and an increasing gold price, gold ounce discovery is not keeping up to the rate needed to replace mined ounces." More >

Good-bye Gasoline: Natural Gas in American Vehicles
Source: Brianna Panzica, Energy and Capital  (12/15/12)
"It began with the oil and gas companies, and now it's moving to state fleets. Soon enough, there will be natural gas vehicles on every block." More >

How to Find Success with Latin American Miners: Heiko Ihle
Source: Brian Sylvester of The Gold Report   (12/14/12)
Miners in Latin America are facing both growth and challenges. Heiko Ihle, senior research analyst with Euro Pacific Capital, examines the factors behind these trends. In this Gold Report interview, Ihle urges investors to evaluate mining companies based on three important features rather than on the performance of others in the region. More >

Confiscation of Gold - Then What? Part 1
Source: Julian Phillips, Gold Forecaster  (12/14/12)
"If gold is re-rated to a level I asset, as is proposed by Basel III (U.S. bankers are in on the discussions) then there is not enough readily-available gold to provide both the central banks of the world and the banking system with sufficient for gold to play this role." More >

Gold: A Look Back and a Look Forward
Source: Peter Degraaf, Itiswell  (12/14/12)
"The average gold correction of 10% or more has resulted in a delay of 12–19 months before a new record high was established." More >

Gold Prices: Where to Now After the Sell-Off?
Source: Deborah Baratz, Money Morning  (12/14/12)
"Investors are expected to come back and buy gold since it's a hedge for inflation and uncertainty." More >

Zacks Analyst Jason Napodano's Six Biotech Picks Will Keep Your Profits on Solid Ground
Source: George S. Mack of The Life Sciences Report   (12/13/12)
Low valuation in biotech can be like quicksand under a mirage of low-hanging fruit. That's because the market is inhabited by growth investors who think cheap stocks are cheap for a reason. Zacks Investment Research Senior Biotechnology Analyst Jason Napodano operates with this in mind as he evaluates biotech companies. He also understands that while value can be a good friend, an investor's best buddy is momentum powered by vital market-moving events. Napodano shares his best stock ideas in this Life Sciences Report interview. More >

Do You Have the Guts to Take On Cutting-Edge Biotech Like This VC?
Source: George S. Mack of The Life Sciences Report  (12/13/12)
With the odds stacked against a drug entering clinical trials, investors need to be assured that the upside will be momentous when success does come. Burrill & Co. Managing Director Elemer Piros leverages science and the unmet needs of patients with his extensive knowledge of the capital markets to bring lower-risk, higher-return ideas to investors. In this interview with The Life Sciences Report, Piros explains his investment thesis and zeroes in on best bets. More >

Porter Stansberry: End the Ban on US Oil Exports
Source: Karen Roche of The Energy Report  (12/13/12)
Porter Stansberry doesn't mince words. Politicians? Scumbags. People in general? Lazy. Laws against oil exports? Disastrous. In this interview with The Energy Report, the Stansberry & Associates Investment Research founder argues that oil exports could usher in an era of unprecedented prosperity, if legislation would only allow it. However, he says there's no holding back U.S. energy wealth; the profits will sprout up in oil- and gas-related industries like fertilizer, petrochemicals and shipping. Find out where Stansberry is putting his money. This time, it's not on E&Ps. More >

Will the Japanese Election Spark a Rebound in Uranium?
Source: Jeb Handwerger, Gold Stock Trades  (12/13/12)
"Look for a reversal in the near term and break above the recent downtrend." More >

Why Oil Is a 'Must-Have' Profit Play for 2013
Source: Kent Moors, Oil & Energy Investor  (12/13/12)
"A number of factors may push Brent and WTI prices higher next year, particularly in the first quarter." More >

Stability and Patience Are the Keys for Rare Earth Investing
Source: Geoff Candy, Mineweb  (12/13/12)
"House Mountain Partners' Chris Berry explained that an investment in the space now requires a 'belief in the management of a company and the location, the geo-political story surrounding the deposit.' And, more importantly a clear view of the company’s financial sustainability." More >

Fear Versus Fundamentals in the Platinum Market
Source: Louis James, Casey Research  (12/13/12)
Although the platinum market is now estimated to end the year in deficit, unless there's a new and even greater supply disruption, the existing recycling output will likely adapt and fill in the 2012 supply gap rather quickly, especially if prices move up. More >

The Next Profit Breakthrough: Synthetic Biology
Source: Michael Robinson, Money Morning  (12/13/12)
"Teams all over the world are now in their labs looking to create novel biotech compounds or drugs by inserting synthetic DNA into cells, either living or artificial." More >

You Say You Want a Revolution. . .
Source: Patrick Cox, The Daily Reckoning  (12/13/12)
"As investors, we have a huge opportunity to invest in early-stage, revolutionary companies working on plant- and animal-based health solutions that bypass the lengthy and extremely expensive FDA approval process." More >

Two Biotech Names Without the Microcap Roller Coaster
Source: George S. Mack of The Life Sciences Report  (12/13/12)
Investors familiar with Zacks Investment Research know that the company is small-cap focused and that it leans heavily toward companies that don't get much coverage from Wall Street. The idea is to produce the kind of sophisticated research you might find in the more recognizable names that get aired on financial television and other media. Battered and forgotten names can be interesting for investors willing to take another look, and biotech can be a particularly rich field for investors looking for turnaround ideas. In fact, this is where Zacks Senior Biotechnology Analyst Jason Napodano is at home. He's not afraid to go all-in with ideas that are anathema to the Street. More >

How to Buy Silver: The Best Is Yet To Come in 2013
Source: Larry Spears, Money Morning  (12/12/12)
"Purists view holding actual physical precious metals like gold and silver as the only true means of hedging against inflation and gaining an effective long-term store of value." More >

Porter Stansberry: Gold and Real Estate Are My Hedges for the Fiscal Cliff
Source: Karen Roche of The Gold Report   (12/12/12)
With nary a glimmer of hope that economic sense will supplant political expedience, Stansberry & Associates Investment Research Founder Porter Stansberry expects rampant inflation to roar in once the cost of capital rises. How is he preparing himself? Stansberry tells The Gold Report he continues to buy and hold gold and also discusses how real estate can cushion against the fiscal cliff. More >

How Gold Miners Can Leverage the Price of Gold
Source: Frank Holmes, Frank Talk  (12/12/12)
"Gazing into their crystal balls last week, Wall Street firms interpreted differing futures for gold next year. Morgan Stanley awarded gold the 'best commodity for 2013' while Goldman Sachs called the end of the metal’s hot streak." More >

Cliff Spells Danger for Biotechs
Source: Alex Philippidis, Genetic Engineering and Biotechnology News  (12/12/12)
"If Obama and Congress cannot agree, key agencies face cuts while tax changes would dampen new investment." More >